Kao CY - Search Results

1

Genetic modification of donor hepatocytes improves therapeutic efficacy for hemophilia B in mice.

Wu YM, Kao CY, Huang YJ, Yu IS, Lee HS, Lai HS, Lee PH, Lin CN, Lin SW. Wu YM, et al. Among authors: kao cy. Cell Transplant. 2010;19(9):1169-80. doi: 10.3727/096368910X503398. Epub 2010 Apr 21. Cell Transplant. 2010. PMID: 20412633 Free article.

2

FIX-Triple, a gain-of-function factor IX variant, improves haemostasis in mouse models without increased risk of thrombosis.

Kao CY, Lin CN, Yu IS, Tao MH, Wu HL, Shi GY, Yang YL, Kao JT, Lin SW. Kao CY, et al. Among authors: kao jt. Thromb Haemost. 2010 Aug;104(2):355-65. doi: 10.1160/TH09-11-0792. Epub 2010 Jun 10. Thromb Haemost. 2010. PMID: 20539913

3

Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo.

Kao CY, Yang SJ, Tao MH, Jeng YM, Yu IS, Lin SW. Kao CY, et al. Thromb Haemost. 2013 Aug;110(2):244-56. doi: 10.1160/TH13-02-0154. Epub 2013 May 16. Thromb Haemost. 2013. PMID: 23676890

4

Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B.

Kao CY, Lin CN, Yang YL, Hamaguchi N, Yang SJ, Shen MC, Kao JT, Lin SW. Kao CY, et al. Among authors: kao jt. Thromb Haemost. 2011 Apr;105(4):616-26. doi: 10.1160/TH10-11-0762. Epub 2011 Feb 8. Thromb Haemost. 2011. PMID: 21301787

5

Gene targeting and expression analysis of mouse Tem1/endosialin using a lacZ reporter.

Huang HP, Hong CL, Kao CY, Lin SW, Lin SR, Wu HL, Shi GY, You LR, Wu CL, Yu IS. Huang HP, et al. Among authors: kao cy. Gene Expr Patterns. 2011 Jun-Jul;11(5-6):316-26. doi: 10.1016/j.gep.2011.03.001. Epub 2011 Mar 22. Gene Expr Patterns. 2011. PMID: 21402174

6

Versatile Stimuli-Responsive Controlled Release of Pinanediol-Caged Boronic Esters for Spatiotemporal and Nitroreductase-Selective Glucose Bioimaging.

Kao CY, Chen YW, Liu YC, Wei JH, Wang TA. Kao CY, et al. ACS Sens. 2025 Jan 3. doi: 10.1021/acssensors.4c02811. Online ahead of print. ACS Sens. 2025. PMID: 39750141

7

O-antigen of uropathogenic Escherichia coli is required for induction of neutrophil extracellular traps.

Lin WH, Sheu SM, Wu CF, Huang WC, Hsu LJ, Yu KC, Cheng HC, Kao CY, Wu JJ, Wang MC, Teng CH. Lin WH, et al. Among authors: kao cy. J Microbiol Immunol Infect. 2024 Dec 25:S1684-1182(24)00233-0. doi: 10.1016/j.jmii.2024.12.007. Online ahead of print. J Microbiol Immunol Infect. 2024. PMID: 39725572 Free article.

8

Serial changes in metabolic dysfunction-associated steatotic liver disease after sleeve gastrectomy and their associations with abdominal adiposity: a prospective cohort study.

Yang CY, Chen JH, Chen CY, Kao CY, Huang SF, Chang WY, Tu HP, Huang JF, Yu ML, Tai CM. Yang CY, et al. Among authors: kao cy. Surg Obes Relat Dis. 2024 Nov 29:S1550-7289(24)00908-0. doi: 10.1016/j.soard.2024.11.007. Online ahead of print. Surg Obes Relat Dis. 2024. PMID: 39706718

9

Molecular characterization of colistin-resistant Klebsiella pneumoniae isolates and their conjugative mcr-carrying plasmids.

Kao CY, Kuo PY, Lin CC, Cheng YY, Wang MC, Chen YC, Lin WH. Kao CY, et al. J Infect Public Health. 2024 Dec;17(12):102588. doi: 10.1016/j.jiph.2024.102588. Epub 2024 Nov 7. J Infect Public Health. 2024. PMID: 39566127 Free article.

10

An integrated platform for investigating drug-microbial interactions to support pharmacomicrobiomics studies.

Tai YH, Kao CY, Zhang YP, Chiou YJ, Chiu HH, Thuy TTD, Liao HW. Tai YH, et al. Among authors: kao cy. Talanta. 2025 Feb 1;283:127094. doi: 10.1016/j.talanta.2024.127094. Epub 2024 Oct 24. Talanta. 2025. PMID: 39467441

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

505 results

Search Page

Filters